Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
暂无分享,去创建一个
F. Passamonti | M. Maffioli | L. Antolini | C. Gambacorti-Passerini | A. Iurlo | T. Intermesoli | M. Rossi | C. Elena | E. Bono | E. Pungolino | E. Elli | M. D'adda | F. Lunghi | C. Bucelli | N. Polverelli | M. Carraro | M. Gemelli | Michela Anghileri | Mattia Bacciocchi | M. D’adda